BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 7668529)

  • 1. The soluble interleukin-6 receptor.
    Rose-John S; Ehlers M; Grötzinger J; Müllberg J
    Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells.
    Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC
    J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism.
    Hui W; Bell M; Carroll G
    Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding.
    Smith DK; Treutlein HR
    Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A ciliary neurotrophic factor-sensitive human myeloma cell line.
    Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B
    Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
    Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
    J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor.
    Thiel S; Behrmann I; Timmermann A; Dahmen H; Müller-Newen G; Schaper F; Tavernier J; Pitard V; Heinrich PC; Graeve L
    Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):15-9. PubMed ID: 10085222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein.
    Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H
    J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain.
    Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H
    Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components.
    Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S
    Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designer cytokines: targeting actions to cells of choice.
    Economides AN; Ravetch JV; Yancopoulos GD; Stahl N
    Science; 1995 Nov; 270(5240):1351-3. PubMed ID: 7481821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor.
    Di Marco A; Gloaguen I; Demartis A; Saggio I; Graziani R; Paonessa G; Laufer R
    J Biol Chem; 1997 Sep; 272(37):23069-75. PubMed ID: 9287306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
    Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
    J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
    Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
    J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ciliary neurotrophic factor and leukemia inhibitory factor].
    Matsuoka I
    Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):496-503. PubMed ID: 9162989
    [No Abstract]   [Full Text] [Related]  

  • 18. Cloning and characterization of a specific receptor for mouse oncostatin M.
    Lindberg RA; Juan TS; Welcher AA; Sun Y; Cupples R; Guthrie B; Fletcher FA
    Mol Cell Biol; 1998 Jun; 18(6):3357-67. PubMed ID: 9584176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling.
    He W; Gong K; Smith DK; Ip NY
    FEBS Lett; 2005 Aug; 579(20):4317-23. PubMed ID: 16051226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L; Liu F; Vernallis AB; Aubin JE
    J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.